A Comparative Efficacy of Amitriptyline, Gabapentin, and Pregabalin in Neuropathic Cancer Pain

No abstract is available for this paper.

• Publication year

  2012

• Venue

  The American journal of hospice & palliative care

• Publication date

  2012-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/1049909111412539PMID 21745832
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pregabalin

  2012cited by this paper
• Management of Neuropathic Pain

  2006cited by this paper
• Morphine, gabapentin, or their combination for neuropathic pain.

  2005cited by this paper
• Motor Cortex Stimulation for Central and Neuropathic Facial Pain: A Prospective Study of 10 Patients and Observations of Enhanced Sensory and Motor Function during Stimulation

  2005cited by this paper
• Morphine, gabapentin, or their combination for neuropathic pain.

  2005cited by this paper
• Pregabalin relieves symptoms of painful diabetic neuropathy

  2004cited by this paper
• Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double‐blind, placebo‐controlled trial

  2004cited by this paper
• Differential Analgesic Sensitivity of Two Distinct Neuropathic Pain Models

  2004cited by this paper
• Gabapentin in the treatment of neuropathic pain

  2004cited by this paper
• Pregabalin reduces pain and improves sleep and mood disturbances in patients with post‐herpetic neuralgia: results of a randomised, placebo‐controlled clinical trial

  2004influential reference
• The Pattern of Gabapentin Use in a Tertiary Palliative Care Unit

  2003cited by this paper
• Opioids versus antidepressants in postherpetic neuralgia: A randomized, placebo-controlled trial

  2003cited by this paper
• Pregabalin for the treatment of postherpetic neuralgia

  2003cited by this paper
• Neuropathic Pain Study Group

  2003cited by this paper
• Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials.

  2003cited by this paper
• Gabapentin in neuropathic pain syndromes: a randomised, double‐blind, placebo‐controlled trial

  2002cited by this paper
• Opioids versus antidepressants in postherpetic neuralgia: A randomized, placebo-controlled trial

  2002cited by this paper
• Adjunctive Agents in the Management of Chronic Pain

  2001cited by this paper
• Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study

  2001cited by this paper
• Stimulus-dependent modulation of [(3)H]norepinephrine release from rat neocortical slices by gabapentin and pregabalin.

  2000cited by this paper
• Stimulus-Dependent Modulation of [ 3 H ] Norepinephrine Release from Rat Neocortical Slices by Gabapentin and Pregabalin 1

  2000cited by this paper
• Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy.

  2000influential reference
• Gabapentin vs. amitriptyline in painful diabetic neuropathy: an open-label pilot study.

  2000cited by this paper
• Gabapentin as an adjuvant to opioid analgesia for neuropathic cancer pain.

  1999cited by this paper
• Gabapentin for the Symptomatic Treatment of Painful Neuropathy in Patients With Diabetes Mellitus: a Randomized Controlled Trial

  1999cited by this paper
• Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain.

  1999cited by this paper
• Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

  1998cited by this paper
• Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial.

  1998cited by this paper
• Classification of Chronic Pain—Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms

  1995influential reference
• Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. Prepared by the International Association for the Study of Pain, Subcommittee on Taxonomy.

  1994cited by this paper
• Analgesic activity of calcitonin in patients with painful osteolytic metastases of breast cancer

  1987cited by this paper
• Analgetic activity of calcitonin in patients with painful osteolytic metastases of breast cancer. Results of a controlled randomized study.

  1986cited by this paper

• Cancer-Induced Neuropathic Pain: Clinical Features and Treatment Options

  2025cites this paper
• A Comparative Study on the Efficacy, Safety and Cost Effectiveness of Gabapentin and Pregabalin in the Treatment of Neuropathic Pain

  2025influential citation
• Neuroprotective Role of Albizia lebbeck Leaves Against Cisplatin‐Induced Neuropathic Pain via Modulating NF‐κB Signalling Pathway

  2025cites this paper
• Co-treatment with Gabapentinoid and Japanese Herbal Medicine Goshajinkigan for CIPN is Associated with Longer Duration and Higher Dose of Chemotherapy

  2025cites this paper
• Efficacy and safety of pregabalin in the management of low back pain: a comprehensive meta-analysis

  2025cites this paper
• Novel approaches to clinical trial design in cancer neuroscience.

  2025cites this paper
• Management of Chronic Post-Endodontic Pain with a Standardized Gabapentin Pyramid Protocol: A Case Series and Clinical Guidelines.

  2025cites this paper
• Gabapentin dan Gabapentin-Amitriptilin sebagai Adjuvan Analgetik Nyeri Kanker di Klinik Nyeri RSUP H. Adam Malik Medan

  2025cites this paper
• Pregabalin vs. gabapentin in the treatment of neuropathic pain: a comprehensive systematic review and meta-analysis of effectiveness and safety

  2025cites this paper
• Neuropathic Pain in Cancer: What Are the Current Guidelines?

  2024cites this paper
• γ-aminobutyric acid receptor B signaling drives glioblastoma in females in an immune-dependent manner

  2024cites this paper
• Analgesic treatment for refractory cancer pain caused by gastric cancer bone metastasis: A case report and literature review

  2024cites this paper
• A Review of Mechanisms, Impact, and Advances in Management Strategies in Cancer-Related Pain

  2024cites this paper
• Assessment of neuropathic pain management knowledge, attitudes, and practices among urology trainees and consultants in prostate cancer care: a survey-based study

  2024cites this paper
• An evaluation of the adequacy of Indian national and state essential medicines lists (EMLs) for palliative care medical needs—a comparative analysis

  2024cites this paper
• Head-and-neck Cancer in the Emergency Department: A Contemporary Review of Common Presentations and Management

  2024cites this paper
• Evaluating the Effects of Pregabalin, Gabapentin, and Amitriptyline for Treatment of Neuropathic Pain in Cancer Patients

  2024cites this paper
• Clinical effectiveness and treatment satisfaction between two triple‐therapy regimens in treating neuropathic pain: A real‐world data

  2023cites this paper
• Therapeutic Advantages of Mirogabalin and Pregabalin Over Current Treatments for Chemotherapy-Induced Peripheral Neuropathy

  2023cites this paper
• Mechanisms of cancer pain

  2023cites this paper
• Schmerztherapie in der Palliativmedizin

  2023cites this paper
• Daily pain and opioid administration in hospitalized patients with cancer: the importance of psychological factors, recent surgery, and current opioid use.

  2023cites this paper
• Pharmacologic Management of Cancer-Related Pain in Pregnant Patients

  2023cites this paper
• Clinical Presentation and Management of Malignant Psoas Syndrome: A Scoping Review of Case Reports and Case Series

  2023cites this paper
• Pregabalin versus Gabapentin Efficacy in the Management of Neuropathic Pain Associated with Failed Back Surgery Syndrome

  2023cites this paper
• Antidepressants for pain management in adults with chronic pain: a network meta-analysis.

  2023cites this paper
• Opioid analgesics for nociceptive cancer pain: A comprehensive review

  2023cites this paper
• Palliative Care in Drug Resistance Tuberculosis: An Overlooked Component in Management

  2023cites this paper
• Head and Neck Cancer-Related Pain.

  2022cites this paper
• Gabapentinoids for Pain: A Review of Published Comparative Effectiveness Trials and Data Submitted to the FDA for Approval

  2022cites this paper
• Systemic Lidocaine Infusions for Pediatric Patients with Cancer-Related Pain

  2022influential citation
• Palliative cancer patients pain reduction methods during opioid epidemic era

  2022cites this paper
• Efficacy and Safety of Pregabalin Prolonged Release–Etoricoxib Combination Compared to Etoricoxib for Chronic Low Back Pain: Phase 3, Randomized Study

  2022cites this paper
• Antitumoral Effects of Tricyclic Antidepressants: Beyond Neuropathic Pain Treatment

  2022cites this paper
• Pregabalin Silences Oxaliplatin-Activated Sensory Neurons to Relieve Cold Allodynia

  2022cites this paper
• Treatment of Neuropathic Pain Directly Due to Cancer: An Update

  2022cites this paper
• Revision of Pharmacological Treatment Recommendations for Cancer Pain: Clinical Guidelines from the Japanese Society of Palliative Medicine

  2022cites this paper
• Updates in the Treatment of Chemotherapy-Induced Peripheral Neuropathy

  2022cites this paper
• Pain and Analgesia in Children with Cancer after Hemipelvectomy: A Retrospective Analysis

  2022cites this paper
• Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain: a JORTC-PAL16 trial protocol

  2022cites this paper
• Comparative Benefit–Risk Assessment for Lidocaine 700 mg Medicated Plaster and Pregabalin in Peripheral Neuropathic Pain Following a Structured Framework Approach

  2021cites this paper
• Neuropathischer Schmerz bei Palliativpatienten

  2021cites this paper
• The efficacy of gabapentin combined with opioids for neuropathic cancer pain: a meta-analysis

  2021cites this paper
• Green HPLC-DAD and HPTLC Methods for Quantitative Determination of Binary Mixture of Pregabalin and Amitriptyline Used for Neuropathic Pain Management.

  2021cites this paper
• Peripheral Neuropathy and Pain Caused by Cancer Chemotherapy

  2021cites this paper
• Novel Treatments for Chronic Pain: Moving Beyond Opioids.

  2021cites this paper
• Neoplastic Disease

  2021cites this paper
• Malignant Pelvic Pain

  2021cites this paper
• Palliative Care and Cancer Pain

  2021cites this paper
• Chemotherapy-induced peripheral neuropathy (CIPN): current therapies and topical treatment option with high-concentration capsaicin

  2021cites this paper
• Strategies for Optimizing Perioperative Pain Management for the Cancer Patient.

  2021cites this paper
• Non-opioid Analgesics and Emerging Therapies.

  2021cites this paper
• Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment

  2021cites this paper
• OVERVIEW OF NEUROPATHIC PAIN AND ITS OUTPATIENT MANAGEMENT

  2021cites this paper
• Aktualisierte S3-Leitlinie „Palliativmedizin für Patienten mit einer nicht heilbaren Krebserkrankung“

  2020cites this paper
• Drug Repositioning: Antimalarial Activities of GABA Analogs in Mice Infected with Plasmodium berghei.

  2020cites this paper
• Nonopioid Pharmacologic Treatments for Chronic Pain

  2020cites this paper
• Response to pregabalin and progesterone differs in male and female rat models of neuropathic and cancer pain

  2020cites this paper
• Practice review: Evidence-based and effective management of pain in patients with advanced cancer

  2020cites this paper
• Duloxetine and pregabalin in neuropathic pain of lung cancer patients

  2020cites this paper
• Indian Society for Study of Pain, Cancer Pain Special Interest Group Guidelines on Pharmacological Management of Cancer Pain (Part III)

  2020cites this paper
• Herbal Decoction Divya-Peedantak-Kwath Alleviates Allodynia and Hyperalgesia in Mice Model of Chemotherapy-Induced Peripheral Neuropathy via Modulation in Cytokine Response

  2020cites this paper
• Study on dosage range evaluation opioid analgesic for breakthrough pain in cancer patients: a retrospective study.

  2020cites this paper
• The use of antineuropathic medications for the treatment of chronic pain.

  2020cites this paper
• Implications of Instituting an Enhanced Recovery after Surgery Pathway in Patients Receiving Chemotherapy in Microsurgical Breast Reconstruction

  2020cites this paper
• Comparing Effectiveness of Gabapentin and Pregabalin in Treatment of Neuropathic Pain: A Retrospective Cohort of Palliative Care Outpatients

  2020cites this paper
• Effectiveness of Nerve Blocks for the Management of Head and Neck Cancer Associated Neuropathic Pain Disorders; a Retrospective Study

  2020cites this paper
• Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO-EONS-EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up†.

  2020cites this paper
• Chronic Pain Management in Head and Neck Oncology.

  2020cites this paper
• Approach to Pain in Patients with Central Nervous System Metastases

  2020cites this paper
• Attitude of Japanese palliative care specialists towards adjuvant analgesics cancer-related neuropathic pain refractory to opioid therapy: a nationwide cross-sectional survey

  2019cites this paper
• Cytotoxic effect of Pregabalin on U937 and Molt-4 Leukemic Cells in Vitro

  2019cites this paper
• Reviewing without a Clinical Background Is Detrimental for Cancer Pain Management

  2019cites this paper
• Short-Term Effects of 10% Lidocaine Ointment on Allodynia in Cancer Pain: A Randomized, Double-Blind, Placebo-Controlled Crossover Study

  2019cites this paper
• Recent Developments of Novel Pharmacologic Therapeutics for Prevention of Chemotherapy-Induced Peripheral Neuropathy

  2019cites this paper
• Safety Implications of Low-Dose Amitriptyline in Neuropathic Pain

  2019cites this paper
• Prevention and Management of Chemotherapy-Induced Polyneuropathy

  2019cites this paper
• Additive Duloxetine for Cancer-related Neuropathic Pain Nonresponsive or Intolerant to Opioid-Pregabalin Therapy: A Randomized Controlled Trial (JORTC-PAL08).

  2019cites this paper
• Palliative Schmerztherapie

  2019cites this paper
• The Indian Society for Study of Pain, Cancer Pain Special Interest Group guidelines on pharmacological management of cancer pain (Part III)

  2019influential citation
• PAIN MANAGEMENT IN CANCER

  2019cites this paper
• Prevention of chemotherapy-induced peripheral neuropathy: A review of recent findings.

  2019cites this paper
• Pregabalin for neuropathic pain in adults.

  2019cites this paper
• Orofacial neuropathic pain: a pharmacological approach

  2019cites this paper
• Anticonvulsants in the Treatment of Pain

  2019cites this paper
• Effects of pregabalin on paclitaxel-induced neuropathic pain in rats

  2019cites this paper
• Neuropathic Pain in Pediatric Oncology: A Clinical Decision Algorithm

  2019cites this paper
• [Interprofessional symptom management at the end of life].

  2018cites this paper
• A critical appraisal of gabapentinoids for pain in cancer patients

  2018cites this paper
• Appropriateness of tricyclic antidepressants in the geriatric population: A critical interpretation of existing literature.

  2018cites this paper
• Optimal pain management for patients with cancer in the modern era

  2018cites this paper
• Pregabalin versus gabapentin in the treatment of sciatica: study protocol for a randomised, double-blind, cross-over trial (PAGPROS)

  2018cites this paper
• Interprofessionelle Symptomkontrolle am Lebensende

  2018cites this paper
• Cancer-Related Neuropathic Pain: Review and Selective Topics.

  2018cites this paper
• Updates in palliative care – overview and recent advancements in the pharmacological management of cancer pain

  2018cites this paper
• Ongoing strategies and updates on pain management in gynecologic oncology patients.

  2018cites this paper
• Neuropathic cancer pain: prevalence, pathophysiology, and management

  2018cites this paper
• Evidence-based Management of Cancer Pain.

  2018cites this paper
• Access to colorectal cancer (CRC) chemotherapy and the associated costs in a South African public healthcare patient cohort

  2018cites this paper
• Pharmacological management of neuropathic pain in India: A consensus statement from Indian experts

  2018cites this paper